Objective radiologic assessment of body composition in patients with end-stage liver disease: Going beyond the BMI

Transplantation

Volumn 95, Issue 4, 2013, Pages 617-622

  Cruz, Ruy J ^a,b   Dew, Mary Amanda ^b   Myaskovsky, Larissa ^b,c   Goodpaster, Bret ^b   Fox, Kristen ^b   Fontes, Paulo ^a,b   Dimartini, Andrea ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Assessment liver transplant candidates; Body composition; Cachexia; Radiologic assessment

Indexed keywords

ABDOMINAL RADIOGRAPHY; ABDOMINAL WALL MUSCULATURE; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CACHEXIA; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DISEASE ASSOCIATION; DISEASE SEVERITY; END STAGE LIVER DISEASE; FEMALE; HEIGHT; HUMAN; INTRAABDOMINAL FAT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MUSCLE DISEASE; MUSCLE MASS; MUSCLE MASS LOSS; NONALCOHOLIC FATTY LIVER; OBESITY; POST TREATMENT SURVIVAL; PREDICTIVE VALIDITY; PRIORITY JOURNAL; SUBCUTANEOUS FAT;

ADIPOSITY; ADULT; AGED; BODY MASS INDEX; CACHEXIA; CHI-SQUARE DISTRIBUTION; END STAGE LIVER DISEASE; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LIVER TRANSPLANTATION; MALE; MALNUTRITION; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SUBCUTANEOUS FAT; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874656826     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31827a0f27     Document Type: Article

References (25)

1. Prado CM, Carla MM, Birdsell LA, et al. The emerging role of computerized tomography in assessing cancer cachexia. Curr Opin Support Palliative Care 2009; 3: 269.
2. Goodpaster BH, Thaete FL, Simoneau JA, et al. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46: 1579.
3. Goodpaster BH, Kelley DE, Wing RR, et al. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 1999; 48: 839.
4. Tan B, Birdsell LA, Martin L, et al. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 2009; 15: 6973.
5. Manini TM, Clark BC, Nalls MA, et al. Reduced physical activity increases intermuscular adipose tissue in healthy young adults. Am J Clin Nutr 2007; 85: 377.
6. Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle crosssectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 809.
7. Ohkawa S, Odamaki M, Yoneyama T, et al. Standardized thigh muscle area measured by computed axial tomography as an alternate muscle mass index for nutritional assessment of hemodialysis patients. Am J Clin Nutr 2000; 71: 485.
8. UNOS data on liver transplant recipients by diagnoses and year of transplant. Available at: http://optn.transplant.hrsa.gov. Accessed June 30, 2011.
9. Kopple JD, Greene T, Chumlea WC, et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int 2000; 57: 1688.
10. Kalantar-Zadeh K, Streja E, Kovesdy C, et al. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc 2010; 85: 991.
11. McHugh PP, Shah SH, Johnston TD, et al. Predicting dry weigh in patient with ascites and liver cirrhosis using computed tomography imaging. Hepato-gastroenterology 2010; 57: 591.
12. Montano-Loza AJ, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012; 10: 166.
13. Stenholm S, Harris TB, Rantanen T, et al. Sarcopenic obesityVdefinition, etiology and consequences. Curr Opin Clin Nutr Metab Care 2008; 11: 693.
14. Rustgi VK, Marino G, Rustgi S, et al. Impact of body mass index on graft failure and overall survival following liver transplant. Clin Transplant 2004; 18: 634.
15. Englesbe MJ, Patel SP, He K, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010; 211: 271.
16. Nair S, Cohen DB, Cohen MP, et al. Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation. Am J Gastroenterol 2001;96: 842.
17. Jones JC, et al. Exercise capacity and muscle strength in patients with cirrhosis. Liver Transpl 2012; 18: 146.
18. Carson K, Washington MK, Treem WR, et al. Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient. Liver Transpl Surg 1997; 3: 174.
19. Molloy RM, Komorowski R, Varma RV. Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation. Liver Transpl Surg 1997; 3: 177.
20. Vehmas T, Kairemo KJ, Taavitsainen MJ. Measuring visceral adipose tissue content from contrast enhanced computed tomography. Int J Obes Relat Metab Disord 1996; 20: 570.
21. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998; 85: 115.
22. Mourtzakis M, Prado CM, Lieffers JR, et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008; 33: 997.
23. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755.
24. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9: 629.
25. Baracos VE, Reiman T, Mourtzakis M, et al. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 2010; 91: 1133S.